Trials / Completed
CompletedNCT01448330
A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
A Sequence-randomized, Open-label, Single Dose, Crossover Study to Evaluate Pharmacokinetics and Safety After Oral Administration of Clopidogrel and Aspirin in Free Combination and Fixed-dose Combination as HCP0911 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of clopidogrel and aspirin in free combination as HCP0911.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCP0911 / clopidogrel, aspirin | combination tablet vs coadministration |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-10-07
- Last updated
- 2011-12-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01448330. Inclusion in this directory is not an endorsement.